Regulatory News
Friday, September 9, 2016
UPDATE 3-Teva says aims to launch EpiPen-like device by 2018 in U.S.
Sept 9 (Reuters) - Teva Pharmaceutical Industries Ltd
said Friday it aims to win U.S. approval by late 2017
or early 2018 for its version of Mylan NV's EpiPen
device for treating severe allergic...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment